[ad_1] SAN DIEGO, Oct. 31, 2025 /PRNewswire/ — Company: MoonLake Immunotherapeutics (MLTX) is a Swiss clinical-stage biotechnology company focused on inflammatory diseases driven by interleukin-17 (IL-17), particularly in dermatology and rheumatology. Class Period: March 10, […]
Tag: Robbins LLP
Robbins LLP Informs Investors of the Avantor, Inc. Class Action Lawsuit
[ad_1] SAN DIEGO, Oct. 30, 2025 /PRNewswire/ — Robbins LLPĀ informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Avantor, Inc. (NYSE: AVTR) common stock between March […]
WPP Investors Should Contact Robbins LLP for Information About Leading the WPP Inc. Class Action
[ad_1] SAN DIEGO, Oct. 27, 2025 /PRNewswire/ — Company: WPP PLC (NYSE: WPP) is a global communications company that offers advertising, media management, consultancy, public relations, as well as branding and identity services worldwide. Class […]
ATYR Investors Should Contact Robbins LLP for Information About Leading the aTyr Pharma, Inc. Class Action Lawsuit
[ad_1] SAN DIEGO, Oct. 27, 2025 /PRNewswire/ — Company: aTyr Pharma, Inc. (NASDAQ: ATYR) is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. […]
Cepton, Inc. Stockholders with Large Losses are Encouraged to Contact Robbins LLP for Information About the Class Action Against CPTN
[ad_1] SAN DIEGO, Oct. 17, 2025 /PRNewswire/ — Company: Prior to its merger with Koito Manufacturing Co., Ltd., Cepton, Inc. (NASDAQ: CPTN) was an electronics company focused on the deployment of high performance, mass-market lidar […]











